AI Assistant
Blog
Pricing
Log In
Sign Up
Poor response to platinum-based chemotherapy is associated with
KRAS
mutation and concomitant low expression of
BRAC1
and
TYMS
in NSCLC
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.